ORLANDO, FL—(UPDATED) Through 5 years, TAVI with a self-expanding valve provided clinical outcomes similar to those seen with surgery in an intermediate-risk population, according to continued ...
The first human transcatheter aortic valve implantation (TAVI) in 2002, and several subsequent single-center series, showed the feasibility of this new approach for the treatment of patients with ...
As transcatheter aortic valve implantation (TAVI) gains increasing acceptance, cardiologists and surgeons are exploring additional patient populations who may benefit from the procedure. A new paper ...
New data showing five-year outcomes at a single center with the very earliest transcatheter aortic valve implant (TAVI) devices indicate that they are durable and "may last as long as many surgical ...
Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
NORRISTOWN, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results